In 2023, the share of scientific publications involving international collaboration in drug discovery in the UK stood below 52.56%. From 2024 to 2028, the forecasted data show a consistent upward trend, increasing from 52.56% to 58.77%. Year-on-year growth rates illustrate a gradual rise, with notable increases in each subsequent year. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 suggests a solid trajectory of collaboration growth over this period.
Future trends to watch for include potential impacts of evolving global scientific partnerships and policy changes post-Brexit. Increasing digital collaboration tools and global health challenges may also drive higher international collaboration rates in the UK drug discovery sector.
